iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
51 hedge funds and large institutions have $48.8M invested in iShares Genomics Immunology and Healthcare ETF in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.38% less ownership
Funds ownership: 41.73% → 41.35% (-0.38%)
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$573K | |
| 2 | +$472K | |
| 3 | +$426K | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$296K |
| 5 |
AIA
Ally Invest Advisors
Charlotte,
North Carolina
|
+$226K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$851K | |
| 3 | -$799K | |
| 4 |
CCA
Clearwater Capital Advisors
Hoffman Estates,
Illinois
|
-$542K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$418K |
